Abstract-Mass-directed isolation of the CH 2 Cl 2 /CH 3 OH extract from a marine sponge of the genus Pseudoceratina resulted in the purification of a new antimalarial bromotyrosine alkaloid, psammaplysin H (1), along with the previously isolated analogues psammaplysins G (2) and F (3). The structure of 1 was elucidated following 1D and 2D NMR, and MS data analysis. All compounds were tested in vitro against the 3D7 isolate of Plasmodium falciparum and mammalian cell lines (HEK293 and HepG2), with 1 having the most potent (IC 50 0.41 µM) and selective (>97 fold) antimalarial activity.
Malaria is an infectious disease caused by the protozoan parasite Plasmodium falciparum. Each year around 500 million clinical cases of malaria occur with approximately one million of these cases resulting in death. 1 Natural products have played a key role in antimalarial drug discovery and therapy. [2] [3] [4] [5] Well known antimalarial natural products include quinine and artemisinin, which were first isolated from the SouthAmerican "quinine bark" (Cinchona succiruba) and the Chinese "sweet wormwood" (Artemisia annua), respectively. 6, 7 Numerous antimalarial drugs have subsequently been developed from these two natural products. 7, 8 Unfortunately, most antimalarial drugs have lost effectiveness due to the emergence of drug-resistant Plasmodium strains. [9] [10] [11] Thus there is an urgent need for the discovery and development of new antimalarial drugs.
Recently we have reported the isolation, structure elucidation and antimalarial activity of a number of natural products from a variety of Australian biota, [12] [13] [14] [15] including the bromotyrosine derivatives psammaplysins G (2) and F (3) from a marine sponge belonging to the genus Hyattella. 15 Psammaplysin F (3) displayed some activity towards chloroquine-resistant (Dd2) and chloroquine-sensitive (3D7) P. falciparum lines (IC 50 1.38 µM and 0.867 µM, respectively). Psammaplysin G (2) showed only minimal inhibition at 40 µM against the Dd2 isolate. In order to obtain further analogues of this particular chemical class for structure activity relationship studies, and to further evaluate these molecules as potential antimalarial leads, we performed analytical HPLC and off-line MS data analysis on 50 marine sponges belonging to the order Verongida. This taxonomic order has been the source of numerous bromotyrosine-derived secondary metabolites, many of which contain a distinctive spiroisoxazoline system. [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] HPLC/MS data of the CH 2 Cl 2 /CH 3 OH extract from one Pseudoceratina sp. identified UV-active peaks that contained ion clusters in the (+)-LRESIMS at m/z 787/789/791/793/795, 744/746/748/750/752, and 772/774/776/778/780. The first and second ion clusters were predicted to correspond to psammaplysins G (2) and F (3), respectively. The third ion cluster could not be identified following literature searching, and was thought to correspond to a new brominated natural product. Subsequent mass-directed isolation of the large-scale CH 2 Cl 2 /CH 3 OH extract from marine sponge Pseudoceratina sp. afforded the new bromotyrosine alkaloid, psammaplysin H (1) along with the previously reported analogues psammaplysins G (2) and F (3). 15, 25 This paper reports the isolation, structure elucidation of psammaplysin H (1), as well as comparative antimalarial activity and selectivity studies of this new compound with psammaplysins G (2) and F (3). The freeze-dried and ground marine sponge Pseudoceratina sp. (G319257) was sequentially extracted with n-hexane, CH 2 C NMR spectrum displayed 20 signals, nine of which resonated above δ C 100. The above NMR data was very similar to that of the known bromotyrosine psammaplysin F (3). 25 The main differences between 1 and 3 included the MW and the chemical shifts of the protons and carbons associated with the terminal methylated amine moiety. The MW of 1 was 28 Da greater than that of psammaplysin F (3). In the 1 H and 13 C NMR spectra of 1 the terminal N-CH 3 signal resonated further downfield (δ H 3.11; δ C 52.3), compared to psammaplysin F (δ H 2.56; δ C 32.3). In addition, the methylene linked to the terminal N-CH 3 moiety in 1 was also further downfield (δ H 3.52; δ C 65.3), compared to psammaplysin F (δ H 3.17; δ C 48.9). These data indicated the presence of two additional Nmethyl groups attached to the terminal amine of 1. This was confirmed by HMBC correlations of the N-CH 3 protons at δ H 3.11 to carbons at δ C 65.3 (C-20) and 27.0 (C-19) (Fig. 2) . The above data was essentially identical to the trimethylated amine moiety in purealidin U. 20 The 1 H-1 H COSY and HMBC data analysis further supported the psammaplysin skeleton of 1 as shown in Fig. 2 . The relative configuration of compound 1 was determined on the basis of the optical rotation data comparison and key ROESY correlations (Fig. 2) . The relative configuration of psammaplysin A (4) was previously assigned following X-ray data analysis. 22 This same relative configuration was assumed for psammaplysin H since both compounds had similar optical rotations
With the relative stereochemistry determined, structure 1 was assigned to psammaplysin H.
Compounds 1-3 were all tested in vitro for their ability to inhibit the growth of the 3D7 isolate of P. falciparum ( Table 2 ). The new compound psammaplysin H (1) displayed the most potent in vitro antimalarial activity, with an IC 50 of 0.41 µM. This activity is at least four fold better than psammaplysins G (2) or F (3). Importantly, when the activity of these three analogues was compared against the two mammalian cell lines HEK293 and HepG2, psammaplysin H (1) showed only minimal toxicity at the highest concentration tested (40 µM), giving this compound a parasite-specific selectivity index (SI) of >97. In contrast, psammaplysins G (2) and F (3) were more toxic to these cell lines with IC 50 values between 3.71 and 18.96 µM, respectively (SI 2-5; Table 2 ). This preliminary structure activity data suggests that the substitution of the terminal nitrogen is important for the antimalarial activity and selectivity. In addition, the in silico physicochemical profiling for compounds 1-3 is summarized in Table 2 . The compounds are too large to be considered leads 27 and fail the MW criterion for drug-likeness as defined by Lipinski. 28 However, Leeson 29 has reasoned that the most important oral drug-like properties are actually those that have remained most constant over time. In light of this, compounds 1-3 are well positioned in terms of log P, the so-called "Lord of the Rules", 30 percent polar surface area (%PSA) and hydrogen bond donor count (HBD). Interestingly, Leeson's analysis 29 also found that antiinfectives had the most extreme property profiles of any therapy area.
In conclusion we have isolated a new antimalarial bromotyrosine alkaloid, psammaplysin H, that displays promising activity (IC 50 0.41 µM) towards the 3D7 strain of P. falciparum, and promising selectivity (SI >97) when compared to the human cell lines HEK293 and HepG2. Further chemical investigations around the spiroisoxazoline scaffold are currently underway, which will provide additional structure activity data and assist target identification studies.
Supplemental material available: 1D ( 1 H, 13 C) and 2D (gCOSY, HSQC, gHMBC and ROESY) NMR spectra for psammaplysin H (1), general experimental procedures, sponge collection and identification details, extraction and isolation procedures, biological assay details. Supplemental data associated with this article can be found in the online version at doi: The highest concentration tested was 40 µM which caused 35% ± 10% growth inhibition from 3 assays, thus insufficiently toxic to provide IC50 value.
d The highest concentration tested was 40uM which caused 33% ± 3% growth inhibition from 3 assays, thus insufficiently toxic to provide IC50 value. MW = molecular weight (Da), HBA = H-bond acceptors, HBD = H-bond donors, %PSA = % polar surface area.
